Pre-existing T cell immunity determines the frequency and magnitude of cellular immune response to two doses of mRNA vaccine against SARS-CoV-2
Under a Creative Commons license
open access
Keywords
SARS-CoV-2 humoral response
Cellular response
mRNA vaccine
Pre-existing immunity
Abbreviations
COVID-19
Coronavirus disease 2019
S protein
Spike protein
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
RT-PCR
retrotranscriptasepolymerase chain reaction
CLIA
chemoluminiscent immunoassay
IgG
immunoglobulin G
AU
arbitrary units
Cited by (0)
- 1
These authors contribute equally to this work and share first authorship.
© 2022 The Author(s). Published by Elsevier Ltd.